Speakers

Shenjiang (Shawn) Liu

President & CEO

Avirmax Inc.

Anne Altmeyer

Formerly, CBO

Sigilon Tx

Lili Belcastro

Senior Scientist, Cell Therapy Dev and Ops (CTDO), Technical Center of Excellence (TCoE) for Early Development Raw Materials

BMS

Kapil Bharti

Earl Stadtman Tenure-Track Investigator, National Eye Institute

National Institutes of Health

Kathryn Corzo

Head of Development Oncology Cell Therapies

Takeda

Anthony Davies, Ph.D.

Founder & CEO

Dark Horse Consulting

Marianne De Backer, MBA, PhD

EVP, Head of Strategy, BD&L

Bayer

Roland DeAngelis

SVP, Commercial Operations

Vericel (pernding final confirmation)

David Dobnik

Scientific Associate

National Institute of Biology, Slovenia

Fabien Dorange

Head Analytical CMC

Genethon

Kris Elverum

SVP, BD & Strategy

Rubius Tx

Miguel Forte

CEO

Bone Therapeutics, Belgium

Shin Fuse

Managing Director

MPM Capital

Shaan Gandhi

Director

Northpond Ventures

Chris Gemmiti, Ph.D.

Executive Director of Technical Operations; Head of Early Stage CMC and Product Launch Programs

CRISPR Therapeutics

Fabian Gerlinghaus

Co-Founder & CEO

Cellares

Ruti Goldberg

Compliance and Methods Validations Manager

Pluristem Therapeutics

Brian Goodman, PhD

Partner

MPM

Jennifer Griffin

VP Industrial Strategy & Investments

Mass Life Sciences

Christina Grigoriadou

Senior Scientist

AstraZeneca

Sadik H. Kassim

Chief Technology Officer

Vor Biopharma

Juliette Hilliard

Director, Talent Acquisition

Novartis GT

Nathaniel Hogrebe

Postdoctoral Research Fellow

Jeffrey Millman Laboratory, Washington University School of Medicine, USA

Daniel Hui

Associate Director – Product Characterization/Clinical Assay Development

Tmunity Therapeutics

Gabrielle Humphrey

CMC Consultant

VECTAPLUS (formerly Adaptimmune)

Jeffrey Hung

Chief Commercial Officer

Vigene Biosciences, Inc., USA

Silky Kamdar

Manager

BMS

Katalin Karikó, PhD

Senior Vice President RNA Protein Replacement Therapy

BioNTech

Aleks Katane

Liver Program Manager

Miromatrix, USA

Georgios Katsikis

Postdoctoral Associate

Massachusetts Institute of Technology, USA

Santoshkumar Khatwani

Associate Director, Analytical Development

Sangamo Therapeutics

Michael Klichinsky

Co-Founder and VP, Discovery Research

Carisma Therapeutics

Walter Kowtonuik

Principal

Third Rock

Janet Lambert

Chief Executive Officer

Alliance for Regenerative Medicine

Jane Lebkowski

President

Regenerative Patch Technologies Inc., USA

Raymond Luke

Associate Director, MS&T

Adaptimmune (pending final confirmation)

Marinna Madrid

Co-Founder

Cellino

Muthiah (Mano) Manoharan, PhD

Senior Vice President of Drug Discovery

Alnylam Pharmaceuticals, Inc.

Arkadi Manukyan

Scientist, Analytical Development

Sanofi, USA

John Maraganore, PhD

Chief Executive Officer

Alnylam Pharmaceuticals, Inc

Bruno Marques

Head of Process & Product Development

Century Therapeutics

Krishanu Mathur

CMC, Early & Late Stage Gene Therapy

Voyager Therapeutics, USA

Alex Meola

Scientist II, Downstream Process Development

Homology Medicines

Sheila Mikhail

CEO & Co-Founder

AskBio

Ali Mohamed

VP, CMC

Immatics

Manal Morsy

Senior Vice President, Head Global Regulatory Affairs

Athersys, Inc.

Shashi Murthy, PhD

Founder & CTO

Flaskworks

Tam Nguyen

PhD Candidate

Massachusetts Institute of Technology, USA

Sarah Nikiforow

Asst. Professor, Stem Cell Transplantation Program, Asst. Medical Director, Cell Manipulation Core Facility

Dana-Farber Cancer Institute

Knut Niss

Chief Technology Officer

Mustang Bio

Roland Pach

Project Leader

F.Hoffmann-La Roche, Switzerland

Michal Preminger, Ph.D., MBA

Head, J&J Innovation, East North America

J&J

Lior Raviv

Vice President Development & Operations

Pluristem Therapeutics

Kareem Reda

CBO

Elevate Bio

Lyndi Rice

Head of QC Viral Vector Analytical

BioMarin

Andrew Rigoglioso

Associate Director, Talent Acquisition, Cell Therapy Development & Operations

BMS

Nadine M. Ritter, Ph.D.

President and Analytical Advisor

Global Biotech Experts, LLC

Richard Rogers, Ph.D.

Principal Scientist

Juno Therapeutics (a BMS Company)

Jon A. Rowley, Ph.D.

Founder & Chief Product Officer

RoosterBio Inc.

Shefali Shah

Independent Consultant

Indi

Lara Ionescu Silverman

Senior Director, Research and Development

DiscGenics

Devyn Smith

Chief Executive Officer

Arbor Biotechnologies, Inc.

Sarah Snykers

QC Manager

Celyad

Roy Sorek

Director, Quality Assurance

bluebird bio

Cenk Sumen

Chief Technology Officer

Stemson Therapeutics

Hélène Trottin

Senior Technical Specialist, Process Sciences

Allergan Biologics (an Abbvie company)

Georgette Verdin

Chief HRO

Avrobio

James Dean Vogel

Founder and Director

The BioProcess Institute

Yogesh Waghmare

Director, CMC Lead

bluebird bio

Tom Walls

Global Planning and Logistics Lead

Spark Therapeutics, USA

Greg White

Senior Director , Global Market Access Policy

Janssen

Kristin Wolff

Senior Director, Global Government Affairs & Public Policy

Bluebird

W. Hong Yeo

Assistant Professor of George W. Woodruff School of Mechanical Engineering, Director of the IEN Center for Human-Centric Interfaces and Engineering

Georgia Institute of Technology, USA